Knight Therapeutics | GUD - Trade Creditors

Stock Price
6.31
Daily Change
0.01 0.16%
Monthly
9.36%
Yearly
14.52%
Q1 Forecast
6.28

Knight Therapeutics reported CAD86.03M in Trade Creditors for its fiscal quarter ending in March of 2024.





Trade Creditors Change Date
Acasti Pharma USD 459K 881K Sep/2025
Akebia Therapeutics USD 21.18M 11.1M Dec/2025
Alaunos Therapeutics USD 843K 34K Sep/2025
Aurora Cannabis CAD 49.34M 31.94M Sep/2025
Avita Medical AUD 7.27M 976K Jun/2025
Canopy Growth CAD 18.14M 5.94M Sep/2025
Cronos Group USD 10.86M 1.27M Sep/2025
Dianthus Therapeutics USD 6.7M 1.3M Sep/2025
Ionis Pharmaceuticals USD 14.33M 8.47M Sep/2025
IQVIA Holdings USD 3.75B 201M Dec/2025
Moderna USD 317M 50M Dec/2025
Omeros USD 8.84M 4.42M Jun/2025
Organigram Holdings CAD 89.25M 556K Sep/2025
Organon & Co USD 1.07B 7M Sep/2025
Revvity USD 185.46M 9.66M Dec/2025
Tectonic Therapeutic USD 1.48M 1.32M Sep/2025
Tilray USD 107.35M 8.43M Mar/2025
Viatris USD 1.33B 6.4M Sep/2025
Xeris Pharmaceuticals USD 6.53M 2.93M Sep/2025